Cello Group plc  

(Public, LON:CLL)   Watch this stock  
Find more results for Paul L. Chello
94.50
+0.50 (0.53%)
Aug 28 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
Range 94.50 - 94.50
52 week 81.00 - 106.70
Open 94.00
Vol / Avg. 0.00/91,835.00
Mkt cap 80.97M*
P/E 35.65
Div/yield 1.80/2.75*
EPS 0.03*
Shares 85.23M
Beta     -
Inst. own     -
*GBP

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin -0.08% 1.34%
Operating margin 0.63% 2.48%
EBITD margin - 6.26%
Return on average assets -0.12% 1.89%
Return on average equity -0.21% 3.32%
Employees 919 -
CDP Score - -

Address

11-13 Charterhouse Buildings
LONDON, EC1M 7AP
United Kingdom - Map
+44-20-78128460 (Phone)
+44-20-72535376 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance

Description

Cello Group plc is a United Kingdom-based company engaged in providing market research, consulting and direct marketing services. The Company operates through two segments: Cello Health and Cello Signal. The Cello Health Division provides market research, consulting and communications services principally to the Company's pharmaceutical and healthcare clients. The Cello Signal Division provides market research and direct communications services principally to the Company's consumer facing clients. The Company's online digital community research platform, eVillage offers insights to clients. The Company has offices in the United Kingdom, the United States of America, Singapore and Hong Kong.

Officers and directors

Mark Scott Chief Executive, Executive Director
Mark Bentley Group Finance Director, Company Secretary, Executive Director
Stephen Highley Group Corporate Development Director, Director
Allan Rich Independent Non-Executive Chairman of the Board
William Nigel David Independent Non-Executive Director
Paul Hamilton Senior Independent Non Executive Director